The gut microbiome, kidney disease, and targeted interventions.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1681/ASN.2013080905PMID 24231662PMCID PMC3968507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KEFIRAN REDUCES ATHEROSCLEROSIS IN RABBITS FED A HIGH CHOLESTEROL DIET

  2015cited by this paper
• Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors

  2013cited by this paper
• Chronic kidney disease alters intestinal microbial flora.

  2013cited by this paper
• Bacteria as vitamin suppliers to their host: a gut microbiota perspective.

  2013cited by this paper
• Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process.

  2013cited by this paper
• Oral Activated Charcoal Adsorbent (AST-120) Ameliorates Chronic Kidney Disease-Induced Intestinal Epithelial Barrier Disruption

  2013cited by this paper
• Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction

  2013cited by this paper
• The Long-Term Stability of the Human Gut Microbiota

  2013cited by this paper
• Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease

  2012cited by this paper
• Gut Bacterial Translocation Contributes to Microinflammation in Experimental Uremia

  2012cited by this paper
• Functional interactions between the gut microbiota and host metabolism

  2012cited by this paper
• A metagenome-wide association study of gut microbiota in type 2 diabetes

  2012cited by this paper
• The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis.

  2012cited by this paper
• Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.

  2012cited by this paper
• High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

  2012cited by this paper
• Gut bacterial translocation is associated with microinflammation in end‐stage renal disease patients

  2012cited by this paper
• Intestinal microbiota determine severity of myocardial infarction in rats

  2012cited by this paper
• Bacteria, colonic fermentation, and gastrointestinal health.

  2012cited by this paper
• Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

  2012cited by this paper
• Acid–base status and progression of chronic kidney disease

  2012cited by this paper
• Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

  2012cited by this paper
• Dietary management of chronic kidney disease: protein restriction and beyond

  2012cited by this paper
• Colonic contribution to uremic solutes.

  2011cited by this paper
• The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.

  2011cited by this paper
• Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice

  2011cited by this paper
• Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

  2011cited by this paper
• p‐cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease

  2011cited by this paper
• Management of patients with chronic kidney disease

  2011cited by this paper
• Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.

  2011cited by this paper
• Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.

  2011cited by this paper
• Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies

  2011cited by this paper
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011cited by this paper
• p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease

  2010cited by this paper
• Control of infection by pyroptosis and autophagy: role of TLR and NLR

  2010cited by this paper
• p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.

  2010cited by this paper
• Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome

  2010cited by this paper
• Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

  2010cited by this paper
• Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis

  2010cited by this paper
• Reshaping the gut microbiome with bacterial transplantation and antibiotic intake.

  2010cited by this paper
• Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

  2010cited by this paper
• Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet.

  2010cited by this paper
• Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.

  2010cited by this paper
• Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

  2010cited by this paper
• Long-term impacts of antibiotic exposure on the human intestinal microbiota.

  2010cited by this paper
• Atorvastatin affects TLR4 clustering via lipid raft modulation.

  2010cited by this paper
• Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss

  2010cited by this paper
• Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes

  2010cited by this paper
• Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.

  2009cited by this paper
• Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada

  2009cited by this paper
• Stem cells, self-renewal, and differentiation in the intestinal epithelium.

  2009cited by this paper
• Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

  2009cited by this paper
• Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

  2009cited by this paper
• Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study.

  2009cited by this paper
• Essential oils in the treatment of intestinal dysbiosis: A preliminary in vitro study.

  2009cited by this paper
• Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling

  2009cited by this paper
• Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance

  2009cited by this paper
• Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

  2009cited by this paper
• Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis.

  2009cited by this paper
• Endotoxin-Binding Affinity of Sevelamer Hydrochloride

  2008cited by this paper
• Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort

  2008cited by this paper
• Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics.

  2008cited by this paper
• Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.

  2008cited by this paper
• S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions

  2008cited by this paper
• Effects of Statins on Adipose Tissue Inflammation: Their Inhibitory Effect on MyD88-Independent IRF3/IFN-&bgr; Pathway in Macrophages

  2008cited by this paper
• Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2

  2008cited by this paper
• Innate immunity and intestinal microbiota in the development of Type 1 diabetes

  2008cited by this paper
• Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function.

  2008cited by this paper
• Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.

  2008cited by this paper
• Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects

  2007cited by this paper
• Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

  2007cited by this paper
• Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

  2007cited by this paper
• The role of peptide YY in integrative gut physiology and potential role in obesity

  2007cited by this paper
• The Human Microbiome Project

  2007cited by this paper
• Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.

  2007cited by this paper
• Subclinical vitamin K deficiency in hemodialysis patients.

  2007cited by this paper
• Commensal bacteria modulate cullin‐dependent signaling via generation of reactive oxygen species

  2007cited by this paper
• Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia

  2007cited by this paper
• The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter.

  2007cited by this paper
• The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells

  2007cited by this paper
• Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics.

  2007cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.

  2006cited by this paper
• Increasing body mass index and obesity in the incident ESRD population.

  2006cited by this paper
• Enterocyte TLR4 Mediates Phagocytosis and Translocation of Bacteria Across the Intestinal Barrier

  2006cited by this paper
• Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells

  2006cited by this paper
• A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism.

  2006cited by this paper
• Microbial ecology: Human gut microbes associated with obesity

  2006cited by this paper
• Benefits of a Synbiotic Formula (Synbiotic 2000Forte®) in Critically Ill Trauma Patients: Early Results of a Randomized Controlled Trial

  2006cited by this paper
• Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.

  2006cited by this paper
• Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells.

  2006cited by this paper
• The biology of incretin hormones.

  2006cited by this paper
• Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

  2006cited by this paper
• Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study.

  2006cited by this paper
• Probiotic Amelioration of Azotemia in 5/6th Nephrectomized Sprague-Dawley Rats

  2005cited by this paper
• Comparison of Different Fibers for In Vitro Production of Short Chain Fatty Acids by Intestinal Microflora

  2005cited by this paper
• The gastrointestinal tract in uremia

  2005cited by this paper
• Toll-like receptors.

  2005cited by this paper
• Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

  2005cited by this paper
• Diversity of the Human Intestinal Microbial Flora

  2005cited by this paper
• Host-Bacterial Mutualism in the Human Intestine

  2005cited by this paper

• Association between the gut microbiota and estimated glomerular filtration rate in two Swedish population-based cohorts.

  2026cites this paper
• Gut-Kidney Axis: Unraveling the Role of the Microbiome in Chronic Kidney Disease

  2026cites this paper
• A cross-sectional study of salivary and gut microbiomes in hemodialysis patients with heart failure with preserved ejection fraction

  2026cites this paper
• Liver flukes and kidney injury: systematic review of human and animal data (from 1950 to 2025)

  2026influential citation
• Predicting probiotic success: lessons from Oxalobacter and oxalate metabolism

  2026cites this paper
• Nutritional Modulation of the Gut–Kidney Axis

  2026cites this paper
• Multispecies Probiotic Supplementation in Chronic Kidney Disease (CKD): Insights From Indian Nephrology Experts.

  2026cites this paper
• Mechanisms and clinical implications of gut-brain interactions

  2026cites this paper
• Construction of Chronic Kidney Disease Mouse Model Induced by Diets With Different Adenine Content

  2026cites this paper
• Gut microbiome- targeted intervention ameliorates structural and transcriptomic changes in the kidney of hindlimb unloaded mouse model

  2026cites this paper
• Microbiota management: a perspective for kidney transplant patients.

  2026cites this paper
• How Uremic Toxins Alter Atorvastatin Disposition: Molecular Mechanisms of Inhibition of the Enzyme CYP3A4

  2025cites this paper
• Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential

  2025cites this paper
• Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model

  2025cites this paper
• Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis

  2025cites this paper
• Gut-derived uremic toxins and cardiovascular health in chronic kidney disease

  2025cites this paper
• Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.

  2025cites this paper
• Intestinal pH: a major driver of human gut microbiota composition and metabolism

  2025cites this paper
• Exercise improves endothelial progenitor cell’s function in mice with Type 2 diabetes via gut microbiota modulation

  2025cites this paper
• Gut Microbiome in Patients with Chronic Kidney Disease Stages 4 and 5: A Systematic Literature Review

  2025cites this paper
• Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions

  2025cites this paper
• Pathological Alterations in Human Blood Microbiome—An Updated Review

  2025cites this paper
• The Regulatory Effect of Human Umbilical Cord Mesenchymal Stem Cells on the Gut Microbiota in Diabetic Nephropathy Rats

  2025cites this paper
• Native potential probiotics and postbiotics improve the gut-kidney axis by the modulation of autophagy signaling pathway.

  2025cites this paper
• New insights in the treatment of DKD: recent advances and future prospects

  2025cites this paper
• The Impact of Specific Gut Microbiota Metabolites on Chronic Kidney Disease Progression: Novel Diagnostic Biomarkers and Therapeutic Targets

  2025cites this paper
• Renal aging and its consequences: navigating the challenges of an aging population

  2025cites this paper
• From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research

  2025cites this paper
• Fucoidan alleviates renal fibrosis in mice via Akkermansia muciniphila-mediated suppression of NEU1-TLR4-NFκB signaling axis.

  2025cites this paper
• Insights into the Role of Gut Microbiota Modulation in the Management of Various Cardiovascular Diseases: A New Approach for Improving the Efficacy of Current Cardiovascular Medications.

  2025cites this paper
• Medicine‐Food Plant Polysaccharides Modulate Diabetes and Diabetic Complications Through Maintaining Gut Function: A Review

  2025cites this paper
• New insight into intestinal toxicity accelerated by aged microplastics with triclosan: Inflammation regulation by gut microbiota-bile acid axis.

  2025cites this paper
• Association between the inflammatory potential of diet and chronic renal failure: A cohort study of 163 433 UK Biobank participants.

  2025cites this paper
• Longitudinal serum proteomics identifies inflammatory and metabolic pathways in hypertensive nephrosclerosis progression

  2025cites this paper
• Dual associations of gut and oral microbial networks with kidney transplantation

  2025cites this paper
• Effect of the gut microbiota on frozen shoulder and potential mediating role of inflammatory cytokines: A Mendelian randomization study and mediation analysis.

  2025cites this paper
• Intestinal Microbiota in Early Life: Latest Findings Regarding the Role of Probiotics as a Treatment Approach for Dysbiosis

  2025cites this paper
• Dietary and Nutritional Strategies to Prevent Uremic Toxin Formation and Slow the Progression of Diabetic Kidney Disease

  2025cites this paper
• Gut Microbiota and Membranous Nephropathy: Novel Molecular Mechanisms and Natural Product Therapeutic Strategies

  2025cites this paper
• Serum Indoxyl Sulfate as a Potential Biomarker of Aortic Stiffness in Persons with Type 2 Diabetes Mellitus

  2025cites this paper
• Comprehensive Bibliometric Analysis of Uremic Toxin Research

  2025cites this paper
• Dietary Patterns and Kidney Health: An Umbrella Review of Systematic Reviews and Meta-Analyses.

  2025cites this paper
• Relationship between dietary consumption of live microbes with mortality in adults with chronic kidney disease

  2025cites this paper
• 2bRAD-M reveals circulating microbiome in chronic antibody-mediated rejection (CAMR) and IgA nephropathy (IgAN) after kidney transplantation

  2025cites this paper
• Gut microbiota implication in diabetic kidney disease: mechanisms and novel therapeutic strategies

  2025cites this paper
• Mendelian randomization analysis of gut microbiota-driven immune modulation in rheumatoid arthritis: New mechanistic insights and therapeutic targets

  2025cites this paper
• Interactional Effects of Food Macronutrients with Gut Microbiome: Implications for Host Health and Risk.

  2025cites this paper
• LC-MS/MS identifies elevated imidazole propionate and gut-derived metabolite alterations in peritoneal dialysis patients

  2025cites this paper
• Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease

  2025influential citation
• The Gut-Kidney Axis and Effect on GFR.

  2025cites this paper
• Gut–Kidney Axis Disruption by Antibiotics: Dysbiosis, Renal Dysfunction and Biomarker Insights

  2025cites this paper
• Propionic acid mediates the renoprotective effects of fecal microbiota transplantation against ischemia–reperfusion injury via upregulating GPR43

  2025cites this paper
• Gut alterations in a chronic kidney disease rat model with diet‐induced vascular calcification

  2025cites this paper
• Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure

  2025cites this paper
• Accelerated risk of renal disease progression in pre-ESRD patients with proton pump inhibitors use: a nationwide population-based study

  2024cites this paper
• The Gut–Kidney Axis in Chronic Kidney Diseases

  2024cites this paper
• Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota

  2024cites this paper
• The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions

  2024cites this paper
• Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate

  2024cites this paper
• Recent status and trends of innate immunity and the gut-kidney aixs in IgAN: A systematic review and bibliometric analysis.

  2024cites this paper
• Protective Effect of Probiotic Against Progression of Chronic Kidney Disease: A Randomized Clinical Study

  2024cites this paper
• Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease

  2024cites this paper
• Gut Microbiota in Patients Receiving Dialysis: A Review

  2024cites this paper
• Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease

  2024cites this paper
• Thonningianin A ameliorated renal interstitial fibrosis in diabetic nephropathy mice by modulating gut microbiota dysbiosis and repressing inflammation

  2024cites this paper
• The Efficacy and Safety of Probiotic Combinations Lobun Forte® Versus Renadyl® in Patients With Chronic Kidney Disease: A Comparative, Phase IV, Randomized, Open-Label, Active-Controlled, Parallel Study

  2024cites this paper
• Assessment of the causal relationship between inflammatory bowel diseases and chronic kidney diseases: A two‐sample bidirectional mendelian randomization study among European population

  2024cites this paper
• Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways

  2024cites this paper
• The Effect of Renaltec on Serum Uremic Toxins in Cats with Experimentally Induced Chronic Kidney Disease

  2024cites this paper
• The gut microbiome, chronic kidney disease, and sarcopenia

  2024cites this paper
• The impact of chronic kidney disease on cognitive function

  2024cites this paper
• Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD

  2024cites this paper
• Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease

  2024cites this paper
• Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy

  2024cites this paper
• Unlocking the Potential of Brewers' Spent Grain: A Sustainable Model to Use Beer for Better Outcome in Chronic Kidney Disease.

  2024cites this paper
• Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression

  2024cites this paper
• Differences in the intestinal microbiota and association of host metabolism with hair coat status in cattle

  2024cites this paper
• Nutritional Strategies against Diabetic Nephropathy: Insights from Animal Studies and Human Trials

  2024cites this paper
• Bibliometric Analysis of the Relationship between Gut Microbiota and Chronic Kidney Disease from 2001–2022

  2024cites this paper
• Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients with and without Chronic Kidney Disease.

  2024cites this paper
• The effect of synbiotic supplementation on plasma levels of advanced glycation end products and cardiovascular risk factors in hemodialysis patients: A double‐blind clinical trial

  2024cites this paper
• Gut microbiota dysbiosis and protein energy wasting in patients on hemodialysis: an observational longitudinal study

  2024cites this paper
• Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study

  2024cites this paper
• Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with Traditional Chinese Medicine retention enema in real-world patients with stage 3–5 chronic kidney disease (non-dialysis) based on the theory of the Gut–Kidney axis

  2024cites this paper
• The role of ultra-processed food consumption in protein-energy wasting and sarcopenia development in patients with chronic kidney diseases

  2024cites this paper
• Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV

  2024cites this paper
• Adenine’s impact on mice’s gut and kidney varies with the dosage administered and relates to intestinal microorganisms and enzyme activities

  2024cites this paper
• Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy

  2024cites this paper
• Microbiota analysis in individuals with type two diabetes mellitus and end‑stage renal disease: A pilot study

  2024cites this paper
• Causal relationship between gut microbiota and chronic renal failure: a two-sample Mendelian randomization study

  2024cites this paper
• Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-κB signaling pathway

  2024cites this paper
• Selenium-enriched Bifidobacterium Longum DD98 significantly improves the efficacy of Mesalazine and Cyclosporin A in colitis mice

  2024cites this paper
• Metagenomics and metaproteomics alterations are associated with kidney disease in opisthorchiasis hamsters fed a high-fat and high-fructose diet

  2024cites this paper
• Navigating the microbial maze: unraveling the connection between gut microbiome and pediatric kidney and urinary tract disease

  2024cites this paper
• Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder

  2024cites this paper
• An Anthropometric Analysis Comparing the Effects of Very Low Protein Lactovegetarian and Omnivorous Diets along with Keto analogues

  2024cites this paper
• Pathogenesis of Sarcopenia in Chronic Kidney Disease—The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA

  2024cites this paper
• Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk.

  2023cites this paper
• Derivation and elimination of uremic toxins from kidney-gut axis

  2023cites this paper
• Probiotics mitigate kidney damage after exposure to Sri Lanka's local groundwater from chronic kidney disease with uncertain etiology (CKDu) prevalent area in zebrafish.

  2023cites this paper